<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.jnutbio.com//inpress?rss=yes"><title>The Journal of Nutritional Biochemistry - Articles in Press</title><description>The Journal of Nutritional Biochemistry RSS feed: Articles in Press. Devoted to advancements in nutritional sciences, the  The Journal of Nutritional Biochemistry  presents experimental nutrition 
research as it relates to: biochemistry, neurochemistry, molecular biology, toxicology, physiology and pharmacology. Rigorous reviews 
by an international editorial board of distinguished scientists ensure publication of the most current and key research being conducted 
in nutrition at the cellular, animal and human level. In addition to its monthly features of critical reviews and research communications, 
the  The Journal of Nutritional Biochemistry  also periodically publishes emerging issues, conference summaries, experimental 
methods, symposium reports, metabolic pathways, and short communications.</description><link>http://www.jnutbio.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2010 Published by Elsevier Inc.  </dc:rights><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:issn>0955-2863</prism:issn><prism:publicationDate>2010-03-02</prism:publicationDate><prism:copyright> © 2010 Published by Elsevier Inc.  </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002484/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002435/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002460/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002137/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002125/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002198/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002319/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002149/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002046/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900206X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002101/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002113/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002186/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002228/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002320/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002071/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002095/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002204/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002034/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002058/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002150/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002162/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002216/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900223X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001910/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900165X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001727/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001739/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001806/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001909/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309002083/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001326/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001636/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001648/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001661/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001673/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001697/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001703/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001715/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001740/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001764/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001776/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001788/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900179X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001922/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001934/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS095528630900151X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001405/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001508/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jnutbio.com/article/PIIS0955286309001521/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002484/abstract?rss=yes"><title>Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheep - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002484/abstract?rss=yes</link><description>Abstract: Intrauterine overnutrition is associated with development of cardiovascular disease in adulthood although the underlying mechanism has not been precisely elucidated. This study evaluated the effects of maternal overnutrition on fetal cardiac morphometry and hypertrophy-related mRNA/protein expression. Multiparous ewes were fed either 150% of National Research Council (NRC) nutrient requirements (overfed group) or 100% of NRC requirements (control group) from 60 days before mating to Day 75 (D75) of gestation, when ewes were euthanized. Cardiac morphometry, histology and expression of Akt, forkhead-3a (Foxo3a), glycogen synthase kinase-3β (GSK3β), mammalian target of rapamycin (mTOR), NFATc3 and GATA4, atrial natriuretic factor (ANF), calcineurin A and caspase-8 were examined. Crown rump length, left and right ventricular free wall weights and left ventricular wall thickness were increased in D75 overnourished fetuses. Hematoxylin and eosin staining revealed irregular myofiber orientation and increased interstitial space in heart tissues from overfed group. Masson's trichrome staining displayed myofiber hypertrophy and fascicular disarray in heart tissues from overfed group. Overfeeding significantly enhanced Foxo3a phosphorylation in both ventricles, while protein expression of Akt, Foxo3a, GSK3β and caspase-8 as well as phosphorylated Akt and GSK3β in either ventricle was unaffected. Overfeeding increased left ventricular mTOR, NFATc3 (both total and phosphorylated) and calcineurin A. GATA4, pGATA4 and ANF expression were unchanged in both ventricles. Collectively, our data suggested that overfeeding during early to mid gestation (D75) leads to morphometric changes without overt pathology which may be related to elevated expression of mTOR, NFATc3, calcineurin A and phosphorylation of Foxo3a, mTOR and NFATc3.</description><dc:title>Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheep - Corrected Proof</dc:title><dc:creator>Xiujuan Fan, Subat Turdi, Stephen P. Ford, Yinan Hua, Mark J. Nijland, Meijun Zhu, Peter W. Nathanielsz, Jun Ren</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-03-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-03-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002435/abstract?rss=yes"><title>Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002435/abstract?rss=yes</link><description>Abstract: Increased oxidative stress has been associated with the pathogenesis of chronic cardiac hypertrophy and heart failure. Since allicin suppresses oxidative stress in vitro and in vivo, we hypothesized that allicin would inhibit cardiac hypertrophy through blocking oxidative stress-dependent signaling. We examined this hypothesis using primary cultured cardiac myocytes and fibroblasts and one well-established animal model of cardiac hypertrophy. Our results showed that allicin markedly inhibited hypertrophic responses induced by Ang II or pressure overload. The increased reactive oxygen species (ROS) generation and NADPH oxidase activity were significantly suppressed by allicin. Our further investigation revealed this inhibitory effect on cardiac hypertrophy was mediated by blocking the activation of ROS-dependent ERK1/2, JNK1/2 and AKT signaling pathways. Additional experiments demonstrated allicin abrogated inflammation and fibrosis by blocking the activation of nuclear factor-κB and Smad 2/3 signaling, respectively. The combination of these effects resulted in preserved cardiac function in response to cardiac stimuli. Consequently, these findings indicated that allicin protected cardiac function and prevented the development of cardiac hypertrophy through ROS-dependent mechanism involving multiple intracellular signaling.</description><dc:title>Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways - Corrected Proof</dc:title><dc:creator>Chen Liu, Feng Cao, Qi-Zhu Tang, Ling Yan, Yu-Gang Dong, Li-Hua Zhu, Lang Wang, Zhou-Yan Bian, Hongliang Li</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002460/abstract?rss=yes"><title>Polyphenol-containing azuki bean (Vigna angularis) seed coats attenuate vascular oxidative stress and inflammation in spontaneously hypertensive rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002460/abstract?rss=yes</link><description>Abstract: We investigated the effects of azuki bean (Vigna angularis) seed coats (ABSC), which contain polyphenols, on the vascular oxidative stress and inflammation associated with hypertension. Spontaneously hypertensive rats (SHR) and control normotensive Wistar-Kyoto (WKY) rats were divided into 2 groups each. One group was fed 0% ABSC; the other, a 1.0% ABSC-containing diet. Tail systolic blood pressure (SBP) was examined throughout ABSC treatment. At 8 weeks, vascular superoxide (O2−) production was measured by lucigenin-enhanced chemiluminescence. mRNA expressions of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits, macrophage chemoattractant protein-1 (MCP-1) and its receptor C-C chemokine receptor 2 (CCR2) in the aorta were analyzed by reverse transcriptase-polymerase chain reaction. Protein expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) were determined by western blotting. Polyphenol-containing ABSC suppressed the elevation of SBP throughout the treatment period. The NADPH-stimulated O2− level decreased significantly in the aorta of ABSC-treated SHR compared with the level of untreated SHR. The p47phox and Nox4 mRNA expression increased significantly in untreated SHR compared with that in WKY rats. Conversely, the level of p47phox mRNA was significantly lower in ABSC-treated SHR than in untreated SHR. The protein abundance of both iNOS and COX-2 was significantly decreased in the aorta of the ABSC-treated SHR compared with this abundance in untreated SHR. The MCP-1 and CCR2 mRNA expressions increased in untreated SHR, and these levels were significantly lower in ABSC-treated SHR. In conclusion, our results suggested that polyphenol-containing ABSC could attenuate vascular oxidative stress and inflammation during the progression of hypertension, and this may lead to an improvement in hypertension.</description><dc:title>Polyphenol-containing azuki bean (Vigna angularis) seed coats attenuate vascular oxidative stress and inflammation in spontaneously hypertensive rats - Corrected Proof</dc:title><dc:creator>Yuuka Mukai, Shin Sato</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.11.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-26</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-26</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002137/abstract?rss=yes"><title>Feeding conditions control the expression of genes involved in sterol metabolism in peripheral blood mononuclear cells of normoweight and diet-induced (cafeteria) obese rats - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002137/abstract?rss=yes</link><description>Abstract: Peripheral blood mononuclear cells (PBMC) are easily obtainable cells from blood whose gene expression profiles have been proven to be highly robust in distinguishing a disease state from healthy state. Sterol metabolism is of physiological importance, and although its nutritional response in liver has been described, it is poorly studied in PBMC. To examine if PBMC sterol metabolism reflects diet-induced physiological responses, we analysed the whole genome gene expression response of PBMC and focused on sterol metabolism-related genes affected by different feeding conditions (ad libitum feeding, fasting, and refeeding) in normoweight (control) rats and in diet-induced (cafeteria) obese rats.Our results of microarray analysis show that, in control rats, 21 genes involved in sterol metabolism were regulated by the different feeding conditions, whereas in cafeteria-obese rats, only seven genes showed a changed expression. Most of the genes identified were classified into three pathways: sterol biosynthesis, cholesterol transport and uptake and sterol signaling. The expression profile of these genes was similar to that previously described for liver, decreasing in response to fasting conditions and recovering the levels found in fed animals after 6-h-refeeding. In addition, our data and the comparable expression pattern of sterol metabolism-related genes between PBMC and liver suggest similar sterol regulatory element-binding protein-mediated regulatory mechanisms in response to feeding conditions in both tissues.In conclusion, the expression of genes involved in sterol metabolism is highly controlled by feeding conditions in PBMC of control rats, but this control is impaired in cafeteria-obese animals. The pathophysiological significance of this impairment requires further investigation.</description><dc:title>Feeding conditions control the expression of genes involved in sterol metabolism in peripheral blood mononuclear cells of normoweight and diet-induced (cafeteria) obese rats - Corrected Proof</dc:title><dc:creator>Antoni Caimari, Paula Oliver, Wendy Rodenburg, Jaap Keijer, Andreu Palou</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-22</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-22</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002125/abstract?rss=yes"><title>Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002125/abstract?rss=yes</link><description>Abstract: The nuclear vitamin D receptor (VDR) mediates the actions of 1,25-dihydroxyvitamin D3 (1,25D) to regulate gene transcription. Recently, the secondary bile acid, lithocholate (LCA), was recognized as a novel VDR ligand. Using reporter gene and mammalian two-hybrid systems, immunoblotting, competitive ligand displacement and quantitative real-time PCR, we identified curcumin (CM), a turmeric-derived bioactive polyphenol, as a likely additional novel ligand for VDR. CM (10−5 M) activated transcription of a luciferase plasmid containing the distal vitamin D responsive element (VDRE) from the human CYP3A4 gene at levels comparable to 1,25D (10−8 M) in transfected human colon cancer cells (Caco-2). While CM also activated transcription via a retinoid X receptor (RXR) responsive element, activation of the glucocorticoid receptor (GR) by CM was negligible. Competition binding assays with radiolabeled 1,25D confirmed that CM binds directly to VDR. In mammalian two-hybrid assays employing transfected Caco-2 cells, CM (10−5 M) increased the ability of VDR to recruit its heterodimeric partner, RXR, and steroid receptor coactivator-1 (SRC-1). Real-time PCR studies revealed that CM-bound VDR can activate VDR target genes CYP3A4, CYP24, p21 and TRPV6 in Caco-2 cells. Numerous studies have shown chemoprotection by CM against intestinal cancers via a variety of mechanisms. Small intestine and colon are important VDR-expressing tissues where 1,25D has known anticancer properties that may, in part, be elicited by activation of CYP-mediated xenobiotic detoxification and/or up-regulation of the tumor suppressor p21. Our results suggest the novel hypothesis that nutritionally-derived CM facilitates chemoprevention via direct binding to, and activation of, VDR.</description><dc:title>Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention - Corrected Proof</dc:title><dc:creator>Leonid Bartik, G. Kerr Whitfield, Magdalena Kaczmarska, Christine L. Lowmiller, Eric W. Moffet, Julie K. Furmick, Zachary Hernandez, Carol A. Haussler, Mark R. Haussler, Peter W. Jurutka</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.012</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-15</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-15</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002198/abstract?rss=yes"><title>Vitamin E status and metabolism in adult and aged aryl hydrocarbon receptor null mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002198/abstract?rss=yes</link><description>Abstract: The aryl hydrocarbon receptor (AhR) is involved in regulation of mechanisms for detoxification of xenobiotics, as well as vitamin A metabolism. Vitamin E is a fat-soluble nutrient whose metabolism is initialized via the cytochrome P450 system. Thus, AhR absence could alter hepatic regulation of α-tocopherol metabolism. To test this hypothesis, we assessed vitamin E status in adult (2-5 m) and old (21-22 m), wild-type and AhR-null mice. Plasma α-tocopherol concentrations in AhR-null mice (2.3±1.2 μmol/L, n=19) were lower than those of wild-type mice (3.2±1.2, n=17, P=.0131); those in old mice (3.2±1.2, n=20) were higher than those of adults (2.2±1.0, n=16, P=.0075). Hepatic α-tocopherol concentrations were not different between genotypes, but were nearly double in old (32±8 nmol/g, n=20) as compared with adult mice (17±2, n=16, P&lt;.0001). Hepatic Cyp3a concentrations in AhR-null mice were greater than those in wild-type mice (P=.0011). Genotype (P=.0047), sex (P&lt;.0001) and age (P&lt;.0001) were significant modifiers of liver α-tocopherol metabolite (α-CEHC) concentrations. In general, Cyp3a concentrations correlated with hepatic α-tocopherol (r=0.3957, P&lt;.05) and α-CEHC (r=0.4260, P&lt;.05) concentrations. Since there were no significant genotype differences in the hepatic α- or γ-tocopherol concentrations, AhR-null mice did not have dramatically altered vitamin E metabolism. Since they did have higher hepatic α-CEHC concentrations, these data suggest metabolism was up-regulated in the AhR-null mice in order to maintain the hepatic tocopherol concentrations similar to those of wild-type mice.</description><dc:title>Vitamin E status and metabolism in adult and aged aryl hydrocarbon receptor null mice - Corrected Proof</dc:title><dc:creator>Maret G. Traber, Debbie J. Mustacich, Laura C. Sullivan, Scott W. Leonard, Amelia Ahern-Rindell, Nancy Kerkvliet</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-15</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-15</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002319/abstract?rss=yes"><title>α-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002319/abstract?rss=yes</link><description>Abstract: Vitamin E has long been identified as a major lipid-soluble chain-breaking antioxidant in mammals. α-Tocopherol is a vitamin E component and the major form in the human body. We propose that, besides its direct chain-breaking antioxidant activity, α-tocopherol may exert an indirect antioxidant activity by enhancing the cell's antioxidant system as a Phase II enzyme inducer. We investigated α-tocopherol's inducing effect on Phase II enzymes and its protective effect on acrolein-induced toxicity in a human retinal pigment epithelial (RPE) cell line, ARPE-19. Acrolein, a major component of cigarette smoke and also a product of lipid peroxidation, at 75 μmol/L over 24 h, caused significant loss of ARPE-19 cell viability, increased oxidative damage, decreased antioxidant defense, inactivation of the Keap1/Nrf2 pathway, and mitochondrial dysfunction. ARPE-19 cells have been used as a model of smoking- and age-related macular degeneration. Pretreatment with α-tocopherol activated the Keap1/Nrf2 pathway by increasing Nrf2 expression and inducing its translocation to the nucleus. Consequently, the expression and/or activity of the following Phase II enzymes increased: glutamate cysteine ligase, NAD(P)H:quinone oxidoreductase 1, heme-oxygenase 1, glutathione S-transferase and superoxide dismutase; total antioxidant capacity and glutathione also increased. This antioxidant defense enhancement protected ARPE-19 cells from an acrolein-induced decrease in cell viability, lowered reactive oxygen species and protein oxidation levels, and improved mitochondrial function. These results suggest that α-tocopherol protects ARPE-19 cells from acrolein-induced cellular toxicity, not only as a chain-breaking antioxidant, but also as a Phase II enzyme inducer.</description><dc:title>α-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells - Corrected Proof</dc:title><dc:creator>Zhihui Feng, Zhongbo Liu, Xuesen Li, Haiqun Jia, Lijuan Sun, Chuan Tian, Lihong Jia, Jiankang Liu</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-15</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-15</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002149/abstract?rss=yes"><title>High fat diet-induced animal model of age-associated obesity and osteoporosis - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002149/abstract?rss=yes</link><description>Abstract: Osteoporosis and obesity remain a major public health concern through its associated fragility and fractures. Several animal models for the study of osteoporotic bone loss, such as ovariectomy (OVX) and denervation, require unique surgical skills and expensive set up. The challenging aspect of these age-associated diseases is that no single animal model exactly mimics the progression of these human-specific chronic conditions. Accordingly, to develop a simple and novel model of post menopausal bone loss with obesity, we fed either a high fat diet containing 10% corn oil (CO) or standard rodent lab chow (LC) to 12-month-old female C57Bl/6J mice for 6 months. As a result, CO fed mice exhibited increased body weight, total body fat mass, abdominal fat mass and reduced bone mineral density (BMD) in different skeletal sites measured by dual energy X-ray absorptiometry. We also observed that decreased BMD with age in CO fed obese mice was accompanied by increased bone marrow adiposity, up-regulation of peroxisome proliferator-activated receptor γ, cathepsin k and increased proinflammatory cytokines (interleukin 6 and tumor necrosis factor α) in bone marrow and splenocytes, when compared to that of LC fed mice. Therefore, this appears to be a simple, novel and convenient age-associated model of post menopausal bone loss, in conjunction with obesity, which can be used in pre-clinical drug discovery to screen new therapeutic drugs or dietary interventions for the treatment of obesity and osteoporosis in the human population.</description><dc:title>High fat diet-induced animal model of age-associated obesity and osteoporosis - Corrected Proof</dc:title><dc:creator>Ganesh V. Halade, Md M. Rahman, Paul J. Williams, Gabriel Fernandes</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-11</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-11</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002046/abstract?rss=yes"><title>The skeletal muscle transcript profile reflects accommodative responses to inadequate protein intake in younger and older males - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002046/abstract?rss=yes</link><description>Abstract: Inadequate protein intake initiates adverse changes in skeletal muscle function and structure (i.e., an accommodative response). mRNA level changes due to short-term inadequate dietary protein might be an early indication of subsequent accommodation. The aims of this study were to assess the effects of dietary protein and the diet-by-age interaction on the skeletal muscle transcriptome. Twelve younger (21–43 y) and 10 older (63–79 y) men completed three controlled feeding trials with protein intakes of 0.50 (LPro: lower protein), 0.75 (MPro: medium protein) and 1.00 g protein·kg body weight−1·day−1 (HPro: higher protein). A fasting state biopsy was taken on Day 12 of each trial. Global changes in transcript levels were assessed with Affymetrix genechips and expression patterns determined using self-organizing maps. Nine hundred fifty-eight transcripts were differentially expressed (P&lt;.05) by diet and 853 had a diet-by-age interaction (P&lt;.05). The results for diet alone revealed that LPro was associated with up-regulation of transcripts related to ubiquitin-dependent protein catabolism and muscle contraction and LPro and MPro resulted in up-regulation of transcripts related to apoptosis and down-regulation of transcripts related to cell differentiation, muscle and organ development, extracellular space and responses to stimuli and stress. The diet-by-age effect on protein modification transcripts was consistent with the older males being less responsive to anabolic stimuli (lower protein synthesis at HPro) and more responsive to a catabolic state (protein breakdown at LPro). Changes in skeletal muscle mRNA levels in younger and older males to protein intake near or below the recommended dietary allowance are indicative of an early accommodative response.</description><dc:title>The skeletal muscle transcript profile reflects accommodative responses to inadequate protein intake in younger and older males - Corrected Proof</dc:title><dc:creator>Anna E. Thalacker-Mercer, James C. Fleet, Bruce A. Craig, Wayne W. Campbell</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-10</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-10</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900206X/abstract?rss=yes"><title>Hydroxytyrosol protects against oxidative damage by simultaneous activation of mitochondrial biogenesis and phase II detoxifying enzyme systems in retinal pigment epithelial cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900206X/abstract?rss=yes</link><description>Abstract: Studies in this laboratory have previously shown that hydroxytyrosol, the major antioxidant polyphenol in olives, protects ARPE-19 human retinal pigment epithelial cells from oxidative damage induced by acrolein, an environmental toxin and endogenous end product of lipid oxidation, that occurs at increased levels in age-related macular degeneration lesions. A proposed mechanism for this is that protection by hydroxytyrosol against oxidative stress is conferred by the simultaneous activation of two critically important pathways, viz., induction of phase II detoxifying enzymes and stimulation of mitochondrial biogenesis. Cultured ARPE-19 cells were pretreated with hydroxytyrosol and challenged with acrolein. The protective effects of hydroxytyrosol on key factors of mitochondrial biogenesis and phase II detoxifying enzyme systems were examined. Hydroxytyrosol treatment simultaneously protected against acrolein-induced inhibition of nuclear factor-E2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor coactivator 1 alpha (PPARGC1α) in ARPE-19 cells. The activation of Nrf2 led to activation of phase II detoxifying enzymes, including γ-glutamyl-cysteinyl-ligase, NADPH (nicotinamide adenine dinucleotide phosphate)-quinone-oxidoreductase 1, heme-oxygenase-1, superoxide dismutase, peroxiredoxin and thioredoxin as well as other antioxidant enzymes, while the activation of PPARGC1α led to increased protein expression of mitochondrial transcription factor A, uncoupling protein 2 and mitochondrial complexes. These results suggest that hydroxytyrosol is a potent inducer of phase II detoxifying enzymes and an enhancer of mitochondrial biogenesis. Dietary supplementation of hydroxytyrosol may contribute to eye health by preventing the degeneration of retinal pigment epithelial cells induced by oxidative stress.</description><dc:title>Hydroxytyrosol protects against oxidative damage by simultaneous activation of mitochondrial biogenesis and phase II detoxifying enzyme systems in retinal pigment epithelial cells - Corrected Proof</dc:title><dc:creator>Lu Zhu, Zhongbo Liu, Zhihui Feng, Jiejie Hao, Weili Shen, Xuesen Li, Lijuan Sun, Edward Sharman, Ying Wang, Karin Wertz, Peter Weber, Xianglin Shi, Jiankang Liu</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-10</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-10</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002101/abstract?rss=yes"><title>N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002101/abstract?rss=yes</link><description>Abstract: Obesity is a growing problem that threatens the health and welfare of a large proportion of the human population. The n-3 polyunsaturated fatty acids (PUFA) are dietary factors that have potential to facilitate reduction in body fat deposition and improve obesity-induced metabolic syndromes. The n-3 PUFA up-regulate several inflammation molecules including serum amyloid A (SAA), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in hepatocytes and adipocytes. Actions of these inflammation mediators resemble those of n-3 PUFA in the modulation of many lipid metabolism-related genes. For instance, they both suppress expressions of perilipin, sterol regulatory element binding protein-1 (SREBP-1) and lipoprotein lipase (LPL) to induce lipolysis and reduce lipogenesis. This review will connect these direct or indirect regulating pathways between n-3 PUFA, inflammation mediators, lipid metabolism-related genes and body fat reduction. A thorough knowledge of these regulatory mechanisms will lead us to better utilization of n-3 PUFA to reduce lipid deposition in the liver and other tissues, therefore presenting an opportunity for developing new strategies to treat obesity.</description><dc:title>N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention - Corrected Proof</dc:title><dc:creator>Chen C. Tai, Shih T. Ding</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-10</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-10</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002113/abstract?rss=yes"><title>Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor κB through the repression of IKKα/β phosphorylation - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002113/abstract?rss=yes</link><description>Abstract: Vitamin K is essential for blood coagulation and bone metabolism in mammals. This vitamin functions as a cofactor in the posttranslational synthesis of γ-carboxyglutamic acid (Gla) from glutamic acid residues. However, other functions of vitamin K have been reported recently. We previously found that vitamin K suppresses the inflammatory reaction induced by lipopolysaccharide (LPS) in rats and human macrophage-like THP-1 cells. In this study, we further investigated the mechanism underlying the anti-inflammatory effect of vitamin K by using cultures of LPS-treated human- and mouse-derived cells. All the vitamin K analogues analyzed in our study exhibited varied levels of anti-inflammatory activity. The isoprenyl side chain structures, except geranylgeraniol, of these analogues did not show such activity; warfarin did not interfere with this activity. The results of our study suggest that the 2-methyl-1,4-naphtoquinone ring structure contributes to express the anti-inflammatory activity, which is independent of the Gla formation activity of vitamin K. Furthermore, menaquinone-4, a form of vitamin K2, reduced the activation of nuclear factor κB (NFκB) and inhibited the phosphorylation of IKKα/β after treatment of cells with LPS. These results clearly show that the anti-inflammatory activity of vitamin K is mediated via the inactivation of the NFκB signaling pathway.</description><dc:title>Vitamin K suppresses the lipopolysaccharide-induced expression of inflammatory cytokines in cultured macrophage-like cells via the inhibition of the activation of nuclear factor κB through the repression of IKKα/β phosphorylation - Corrected Proof</dc:title><dc:creator>Yusuke Ohsaki, Hitoshi Shirakawa, Akihito Miura, Puspo E. Giriwono, Shoko Sato, Ai Ohashi, Maiko Iribe, Tomoko Goto, Michio Komai</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-10</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-10</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002186/abstract?rss=yes"><title>Butyrate reduced lipopolysaccharide-mediated macrophage migration by suppression of Src enhancement and focal adhesion kinase activity - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002186/abstract?rss=yes</link><description>Abstract: Macrophage motility is vital in innate immunity. Lipopolysaccharide (LPS)-mediated macrophage migration requires the enhancement of Src expression and enzymatic activity, which can be regulated by inducible nitric oxide synthase (iNOS). As a major short-chain fatty acid with histone deacetylase (HDAC) inhibitor activity, butyrate exerts anti-inflammatory effect by regulating the expression of cytokines. However, the influence of butyrate on macrophage movement was vague. In this study, we observed that butyrate inhibited migration of both RAW264.7 and rat peritoneal macrophages elicited by LPS. Unlike its myeloid relatives (i.e. Lyn, Fgr and Hck) whose expression was almost unaltered in the presence or absence of butyrate in LPS-treated macrophages, LPS-mediated Src induction was greatly suppressed by butyrate and that could be attributable to reduced level of the src transcript. Similar phenomenon was also detected in LPS-treated macrophages exposed to another HDAC inhibitor, trichostatin A (TSA). Consistent with the indispensability of iNOS in promoting macrophage mobilization via Src up-regulation and the activation of both Src and FAK, we did observe concomitant decrement of iNOS, Src and the suppressed activity of Src and FAK in butyrate- or TSA-pretreated macrophages following LPS exposure. These results imply that by virtue of reduction of Src, butyrate could effectively hamper LPS-triggered macrophage locomotion.</description><dc:title>Butyrate reduced lipopolysaccharide-mediated macrophage migration by suppression of Src enhancement and focal adhesion kinase activity - Corrected Proof</dc:title><dc:creator>Ming-Chei Maa, Miao Ying Chang, Ming-Yu Hsieh, Yen-Jen Chen, Ching-Jau Yang, Zuei-Ching Chen, Yung Kuo Li, Chia-Kuang Yen, Ruei-Ren Wu, Tzeng-Horng Leu</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-10</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-10</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002228/abstract?rss=yes"><title>Vitamin E decreases endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002228/abstract?rss=yes</link><description>Abstract: Intestine is the gateway for newly absorbed tocopherols. This organ also plays a crucial role in cholesterol metabolism. Because tocopherols are known to impact cholesterol metabolism in the liver, we hypothesized that tocopherols could also modulate cholesterol metabolism in the intestine. This study aimed to verify this hypothesis and to unveil the mechanisms involved, using Caco-2 cells as a model of the human intestinal cell.Both α- and γ-tocopherol significantly (P&lt;.05) decreased endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells. Tocopherols down-regulated (P&lt;.05) up to half of the genes involved in the cholesterol synthesis pathway, together with CYP27A1, which is involved in oxysterol production. The activity of this enzyme, as well as the levels of intracellular oxysterols, was significantly diminished by tocopherols. Finally, tocopherols significantly reduced ABCA1 mRNA levels in Caco-2 cells.We conclude that tocopherols impair the endogenous synthesis and apo-AI-mediated secretion of cholesterol in Caco-2 cells. This effect involves a down-regulation of genes involved in the cholesterol synthesis pathway, resulting in down-regulation of CYP27A1 which, in turn, diminishes oxysterol concentrations. The outcome is a decrease of LXR activity, resulting in down-regulation of ABCA1. These data reinforce the effect of α- and γ-tocopherol on cholesterol metabolism via gene expression regulation.</description><dc:title>Vitamin E decreases endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells - Corrected Proof</dc:title><dc:creator>Jean-François Landrier, Erwan Gouranton, Emmanuelle Reboul, Nicolas Cardinault, Claire El Yazidi, Christiane Malezet-Desmoulins, Marc André, Marion Nowicki, Maâmar Souidi, Patrick Borel</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-10</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-10</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002320/abstract?rss=yes"><title>Molecular mechanisms involved in the enhancement of mitochondrial malate dehydrogenase activity by calcitriol in chick intestine - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002320/abstract?rss=yes</link><description>Abstract: Mitochondrial malate dehydrogenase (mMDH) from the intestine is the NAD-linked oxidoreductase of the tricarboxylic acid cycle with the highest activity and response to vitamin D treatment in vitamin D-deficient chicks (−D). The aim of this study was to elucidate potential molecular mechanisms by which cholecalciferol or calcitriol enhances the activity of this enzyme. One group of animals used was composed of −D and −D treated with cholecalciferol or with calcitriol. A second group consisted of −D and −D supplemented with high Ca2+ diet. A third group included chicks receiving either a normal or a low Ca2+ diet. In some experiments, animals were injected with cycloheximide. Data showed that either vitamin D (cholecalciferol or calcitriol) or a low Ca2+ diet increases mMDH activity. High Ca2+ diet did not modify the intestinal mMDH activity from −D. The mMDH activity from −D remained unaltered when duodenal cells were exposed to 10−8 mol/L calcitriol for 15 min. The enhancement of mMDH activity by calcitriol was completely abolished by simultaneous cycloheximide injection to −D. mMDH mRNA levels, detected by RT-PCR, indicate that calcitriol did not affect gene expression. In contrast, Western blots show that calcitriol enhanced the protein expression. In conclusion, calcitriol stimulates intestinal mMDH activity by increasing protein synthesis. No response of mMDH activity by rapid effects of calcitriol or activation through increment of serum Ca2+ was demonstrated. Consequently, ATP production would be increased, facilitating the Ca2+ exit from the enterocytes via the Ca2+-ATPase and Na+/Ca2+ exchanger, which participate in the intestinal Ca2+ absorption.</description><dc:title>Molecular mechanisms involved in the enhancement of mitochondrial malate dehydrogenase activity by calcitriol in chick intestine - Corrected Proof</dc:title><dc:creator>Adriana Pérez, Viviana A. Centeno, Nori G. Tolosa de Talamoni</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-10</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-10</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002071/abstract?rss=yes"><title>Different mechanisms of cis-9,trans-11- and trans-10,cis-12- conjugated linoleic acid affecting lipid metabolism in 3T3-L1 cells - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002071/abstract?rss=yes</link><description>Abstract: Conjugated linoleic acid (CLA) has been shown to reduce body fat mass in various experimental animals. It is valuable to identify its influence on enzymes involved in energy expenditure, apoptosis, fatty acid oxidation and lipolysis. We investigated isomer-specific effects of high dose, long treatment of CLA (75.4 μmol/L, 8 days) on protein and gene expression of these enzymes in cultured 3T3-L1 cells. Proteomics identified significant up- or down-regulation of 52 proteins by either CLA isomer. Protein and gene expression of uncoupling protein (UCP) 1, UCP3, perilipin and peroxisome proliferator-activated receptor (PPAR) α increased whereas UCP2 reduced for both CLA isomers. And eight-day treatment of trans-10,cis-12 CLA, but not cis-9,trans-11 CLA, significantly up-regulated protein and mRNA levels of PKA (P&lt;.05), CPT-1 and TNF-α (P&lt;.01). Compared to protein expression, both isomers did not significantly influence the mRNA expression of HSL, ATGL, ACO and leptin. In conclusion, high-dose, long treatment of cis-9,trans-11 CLA did not promote apoptosis, fatty acid oxidation and lipolysis in adipocytes, but may induce an increase in energy expenditure. trans-10,cis-12 CLA exhibited greater influence on lipid metabolism, stimulated adipocyte energy expenditure, apoptosis and fatty acid oxidation, but its effect on lipolysis was not obvious.</description><dc:title>Different mechanisms of cis-9,trans-11- and trans-10,cis-12- conjugated linoleic acid affecting lipid metabolism in 3T3-L1 cells - Corrected Proof</dc:title><dc:creator>Jia-jie Zhai, Zhao-liang Liu, Jie-mei Li, Jian-Ping Chen, Lin Jiang, Dong-mei Wang, Jin Yuan, Jian-Gang Shen, De-Po Yang, Jia-Qi Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-08</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-08</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002095/abstract?rss=yes"><title>TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002095/abstract?rss=yes</link><description>Abstract: The aim of this study was to investigate the interactions of genetic variants in the genes of cholesterol ester transfer protein (CETP) and low-density lipoprotein receptor (LDLR) with high carbohydrate and low fat (HC/LF) diet on lipid profiles in a young and healthy Chinese Han population. Fifty-six healthy subjects (22.89±1.80 years) were given washout diets of 31% fat and 54% carbohydrate for 7 days, followed by HC/LF diets of 15% fat and 70% carbohydrate for 6 days, with no total energy restriction. Serum lipid profiles at baseline, after washout and following HC/LF diets, as well as CETP and LDLR polymorphisms were analyzed. Carriers of B2 allele of CETP TaqIB polymorphism had significantly higher levels of high density lipoprotein cholesterol (HDL-C) and apo A-I in the whole study population after the diet intervention. Notably, males with CETP TaqIB B1B1 experienced significantly increased HDL-C and apo A-I after HC/LF diet. Regarding the LDLR Pvu II polymorphism, both P1P1 subjects and P2 carriers experienced decreased total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels after HC/LF diet with no statistically significant differences between the genotypes. Our results demonstrate that the elevated HDL-C levels after HC/LF diet in healthy Chinese Han youth are associated with CETP TaqI B2 allele while males with B1B1 genotype are more susceptible to the influence of HC/LF diet on their HDL-C levels. The decreased TC and LDL-C levels after HC/LF diet are not associated with LDLR Pvu II polymorphism.</description><dc:title>TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults - Corrected Proof</dc:title><dc:creator>Juan Du, Ding Zhi Fang, Jia Lin, Li Ying Xiao, Xue Dong Zhou, Sarah Shigdar, Wei Duan</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-08</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-08</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002204/abstract?rss=yes"><title>Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002204/abstract?rss=yes</link><description>Abstract: Oxidative stress contributes towards the development of nonalcoholic steatohepatitis (NASH). Thus, antioxidants may decrease oxidative stress and ameliorate the events contributing to NASH. We hypothesized that α- or γ-tocopherol would protect against lipopolysaccharide (LPS)-triggered NASH in an obese (ob/ob) mouse model. Five-week-old obese mice (n=18/dietary treatment) were provided 15 mg/kg each of α- and γ-tocopherol or 500 mg/kg of α- or γ-tocopherol for 5-weeks. Then, all mice were injected ip once with LPS (250 μg/kg) before being sacrificed at 0, 1.5 or 6 h. Body weight and hepatic steatosis were unaffected by tocopherols and LPS. Hepatic α- and γ-tocopherol increased (P&lt;.05) ~9.8- and 10-fold in respective tocopherol supplemented mice and decreased in response to LPS. LPS increased serum alanine aminotransferase (ALT) by 86% at 6 h and each tocopherol decreased this response by 29–31%. By 6 h, LPS increased hepatic malondialdehyde (MDA) and tumor necrosis factor-α by 81% and 44%, respectively, which were decreased by α- or γ-tocopherol. Serum ALT was correlated (P&lt;.05) to hepatic tumor necrosis factor-α (r=0.585) and MDA (r=0.592), suggesting that inflammation and lipid peroxidation contributed to LPS-triggered hepatic injury. α- and γ-Tocopherol similarly attenuated LPS-triggered increases in serum free fatty acid, and α-tocopherol only maintained the LPS-triggered serum triacylglycerol responses at 6 h. These findings indicate that increasing hepatic α- or γ-tocopherol protected against LPS-induced NASH by decreasing liver damage, lipid peroxidation, and inflammation without affecting body mass or hepatic steatosis. Further study is needed to define the mechanisms by which these tocopherols protected against LPS-triggered NASH.</description><dc:title>Dietary α- and γ-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis - Corrected Proof</dc:title><dc:creator>Min-Yu Chung, Steven F. Yeung, Hea Jin Park, Jeff S. Volek, Richard S. Bruno</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-02-08</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-02-08</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002034/abstract?rss=yes"><title>Gestational zinc deficiency affects the regulation of transcription factors AP-1, NF-κB and NFAT in fetal brain - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002034/abstract?rss=yes</link><description>Abstract: Transcription factors AP-1, nuclear factor κB (NF-κB) and NFAT are central to brain development by regulating the expression of genes that modulate cell proliferation, differentiation, apoptosis and synaptic plasticity. This work investigated the consequences of feeding zinc-deficient and marginal zinc diets to rat dams during gestation on the modulation of AP-1, NF-κB and NFAT in fetal brain. Sprague–Dawley rats were fed from gestation day (GD) 0 a control diet ad libitum (25 μg zinc/g diet, C), a zinc-deficient diet ad libitum (0.5 μg zinc/g diet, ZD), the control diet in the amounts eaten by the ZD rats (restrict fed, RF) or a diet containing a marginal zinc concentration ad libitum (10 μg zinc/g diet, MZD) until GD 19. AP-1-DNA binding was higher (50–190%) in nuclear fraction isolated from ZD, RF and MZD fetal brains compared to controls. In MZD fetal brain, high levels of activation of the upstream mitogen-activated protein kinases JNK and p38 and low levels of ERK phosphorylation were observed. Total levels of NF-κB and NFAT activation were higher or similar in the ZD and MZD groups than in controls, respectively. However, NF-κB- and NFAT-DNA binding in nuclear fractions was markedly lower in ZD and MZD fetal brain than in controls (50–80%). The latter could be related to zinc deficiency-associated alterations of the cytoskeleton, which is required for NF-κB and NFAT nuclear transport. In summary, suboptimal zinc nutrition during gestation could cause long-term effects on brain function, partially through a deregulation of transcription factors AP-1, NF-κB and NFAT.</description><dc:title>Gestational zinc deficiency affects the regulation of transcription factors AP-1, NF-κB and NFAT in fetal brain - Corrected Proof</dc:title><dc:creator>Lucila Aimo, Gerardo G. Mackenzie, Alison H. Keenan, Patricia I. Oteiza</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002058/abstract?rss=yes"><title>Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002058/abstract?rss=yes</link><description>Abstract: Dysregulation of myelin sulfatides is a risk factor for cognitive decline with age. Vitamin K is present in high concentrations in the brain and has been implicated in the regulation of sulfatide metabolism. Our objective was to investigate the age-related interrelation between dietary vitamin K and sulfatides in myelin fractions isolated from the brain regions of Fischer 344 male rats fed one of two dietary forms of vitamin K: phylloquinone or its hydrogenated form, 2′,3′-dihydrophylloquinone (dK), for 28 days. Both dietary forms of vitamin K were converted to menaquinone-4 (MK-4) in the brain. The efficiency of dietary dK conversion to MK-4 compared to dietary phylloquinone was lower in the striatum and cortex, and was similar to that in the hippocampus. There were significant positive correlations between sulfatides and MK-4 in the hippocampus (phylloquinone-supplemented diet, 12 and 24 months; dK-supplemented diet, 12 months) and cortex (phylloquinone-supplemented diet, 12 and 24 months). No significant correlations were observed in the striatum. Furthermore, sulfatides in the hippocampus were significantly positively correlated with MK-4 in serum. This is the first attempt to establish and characterize a novel animal model that exploits the inability of dietary dK to convert to brain MK-4 to study the dietary effects of vitamin K on brain sulfatide in brain regions controlling motor and cognitive functions. Our findings suggest that this animal model may be useful for investigation of the effect of the dietary vitamin K on sulfatide metabolism, myelin structure and behavior functions.</description><dc:title>Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides - Corrected Proof</dc:title><dc:creator>Natalia A. Crivello, Sherley L. Casseus, James W. Peterson, Donald E. Smith, Sarah L. Booth</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002150/abstract?rss=yes"><title>An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002150/abstract?rss=yes</link><description>Abstract: Obesity, the related metabolic syndrome and associated liver diseases represent an epidemic problem and demand for effective therapeutic strategies. In this regard, natural compounds derived from Oriental medicine such as green tea polyphenols influencing adipogenesis attract growing attention. In Korea, an aqueous extract from the Japanese spice bush Lindera obtusiloba is traditionally used for treatment of inflammation and prevention of liver damage. We here investigated effects of the L. obtusiloba extract on cell growth, apoptosis, Wnt signaling and differentiation of (im)mature adipocytes using 3T3-L1, an established cell line for studying adipogenesis. L. obtusiloba extract reduced the de‑novo DNA synthesis of 3T3-L1 preadipocytes in a concentration dependent manner with an IC50 of ∼135 μg/ml paralleled by induction of caspase‑3/7 mediated apoptosis. Hormone-induced 3T3‑L1 differentiation in the presence of L. obtusiloba extract resulted in a reduced accumulation of intracellular lipid droplets by 70%, in down-regulated expression of the adipogenesis-associated proteins glucose transporter-4 and vascular endothelial growth factor, in reduced secretion of the proadipogenic matrix metalloproteinase-2, and in dampened phosphorylation of the Wnt pathway effector protein β-catenin with subsequent diminished expression of the peroxisome proliferator-activated receptor-γ. Treatment of mature adipocytes with L. obtusiloba extract also significantly reduced intracellular lipid droplets. In addition to this strong interference of L. obtusiloba extract with adipogenesis, L. obtusiloba extract exerted anti-inflammatory effects. L. obtusiloba extract significantly attenuated lipopolysaccharide- and tumor necrosis factor α-induced secretion of IL-6 by preadipocytes, thus influencing insulin resistance and inflammatory state characterizing obesity. In conclusion, extracts of L. obtusiloba should be evaluated as a potential complementary treatment option for obesity associated with the metabolic syndrome.</description><dc:title>An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes - Corrected Proof</dc:title><dc:creator>Christian Freise, Ulrike Erben, Ulf Neuman, Kiyoung Kim, Martin Zeitz, Rajan Somasundaram, Martin Ruehl</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.013</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002162/abstract?rss=yes"><title>Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002162/abstract?rss=yes</link><description>Abstract: Abscisic acid (ABA) is a natural phytohormone which improves insulin sensitivity and reduces adipose tissue inflammation when supplemented into diets of obese mice. The objective of this study was to investigate the mechanisms by which ABA prevents or ameliorates atherosclerosis. apolipoprotein E-deficient (ApoE−/−) mice were fed high-fat diets with or without ABA for 84 days. Systolic blood pressure was assessed on Days 0, 28, 56 and 72. Gene expression, immune cell infiltration and histological lesions were evaluated in the aortic root wall. Human aortic endothelial cells were used to examine the effect of ABA on 3′,5′-cyclic adenosine monophosphate (cAMP) and nitric oxide (NO) production in vitro. We report that ABA-treated mice had significantly improved systolic blood pressure and decreased accumulation of F4/80+CD11b+ macrophages and CD4+ T cells in aortic root walls. At the molecular level, ABA significantly enhanced aortic endothelial nitric oxide synthase (eNOS) and tended to suppress aortic vascular cell adhesion molecule-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) expression and plasma MCP-1 concentrations. ABA also caused a dose-dependent increase in intracellular concentrations of cAMP and NO and up-regulated eNOS mRNA expression in human aortic endothelial cells. This is the first report showing that ABA prevents or ameliorates atherosclerosis-induced hypertension, immune cell recruitment into the aortic root wall and up-regulates aortic eNOS expression in ApoE−/− mice.</description><dc:title>Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall - Corrected Proof</dc:title><dc:creator>Amir J. Guri, Sarah A. Misyak, Raquel Hontecillas, Alyssa Hasty, Dongmin Liu, Hongwei Si, Josep Bassaganya-Riera</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002216/abstract?rss=yes"><title>Hypocholesterolemic activity of grape seed proanthocyanidin is mediated by enhancement of bile acid excretion and up-regulation of CYP7A1 - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002216/abstract?rss=yes</link><description>Abstract: Interest in grape seed proanthocyanidin (GSP) as a cholesterol-lowering nutraceutical is growing. This study was to investigate the effect of GSP on blood cholesterol level and gene expression of cholesterol-regulating enzymes in Golden Syrian hamsters maintained on a 0.1% cholesterol diet. Results affirmed supplementation of 0.5% or 1.0% GSP could decrease plasma total cholesterol and triacylglycerol level. Western blot and real-time polymerase chain reaction analyses demonstrated GSP did not affect sterol regulatory element binding protein-2 and low-density lipoprotein receptor; however, it increased mRNA 3-hydroxy-3-methylglutaryl coenzyme A reductase. GSP had no effect on the protein mass of liver X receptor alpha (LXRα) but it decreased mRNA LXRα. Most importantly, GSP increased not only the protein level of cholesterol-7α-hydroxylase (CYP7A1) but also mRNA CYP7A1. It was concluded that the hypocholesterolemic activity of GSP was most likely mediated by enhancement of bile acid excretion and up-regulation of CYP7A1.</description><dc:title>Hypocholesterolemic activity of grape seed proanthocyanidin is mediated by enhancement of bile acid excretion and up-regulation of CYP7A1 - Corrected Proof</dc:title><dc:creator>Rui Jiao, Zesheng Zhang, Hongjian Yu, Yu Huang, Zhen-Yu Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2010)</dc:source><dc:date>2010-01-21</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2010-01-21</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900223X/abstract?rss=yes"><title>Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900223X/abstract?rss=yes</link><description>Abstract: Sesamol is a potent phenolic antioxidant which possesses antimutagenic, antihepatotoxic and antiaging properties. Platelet activation is relevant to a variety of acute thrombotic events and coronary heart diseases. There have been few studies on the effect of sesamol on platelets. Therefore, the aim of this study was to systematically examine the detailed mechanisms of sesamol in preventing platelet activation in vitro and in vivo. Sesamol (2.5−5 μM) exhibited more potent activity of inhibiting platelet aggregation stimulated by collagen than other agonists. Sesamol inhibited collagen-stimulated platelet activation accompanied by [Ca2+]i mobilization, thromboxane A2 (TxA2) formation, and phospholipase C (PLC)γ2, protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) phosphorylation in washed platelets. Sesamol markedly increased cAMP and cGMP levels, endothelial nitric oxide synthase (eNOS) expression and NO release, as well as vasodilator-stimulated phosphoprotein (VASP) phosphorylation. SQ22536, an inhibitor of adenylate cyclase, markedly reversed the sesamol-mediated inhibitory effects on platelet aggregation and p38 MAPK phosphorylation, and sesamol-mediated stimulatory effects on VASP and eNOS phosphorylation, and NO release. Sesamol also reduced hydroxyl radical (OH●) formation in platelets. In an in vivo study, sesamol (5 mg/kg) significantly prolonged platelet plug formation in mice. The most important findings of this study demonstrate for the first time that sesamol possesses potent antiplatelet activity, which may involve activation of the cAMP-eNOS/NO-cGMP pathway, resulting in inhibition of the PLCγ2-PKC-p38 MAPK-TxA2 cascade, and, finally, inhibition of platelet aggregation. Sesamol treatment may represent a novel approach to lowering the risk of or improving function in thromboembolism-related disorders.</description><dc:title>Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase - Corrected Proof</dc:title><dc:creator>Chao C. Chang, Wan J. Lu, Cheng W. Chiang, Thanasekaran Jayakumar, Eng T. Ong, George Hsiao, Tsorng H. Fong, Duen S. Chou, Joen R. Sheu</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.10.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-16</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-16</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001910/abstract?rss=yes"><title>Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001910/abstract?rss=yes</link><description>Abstract: Echinacea preparations were the top-selling herbal supplements or medicines in the past decade; however, there is still frequent misidentification or substitution of the Echinacea plant species in the commercial Echinacea products with not well chemically defined compositions in a specific preparation. In this report, a comparative metabolomics study, integrating supercritical fluid extraction, gas chromatography/mass spectrometry and data mining, demonstrates that the three most used medicinal Echinacea species, Echinacea purpurea, E. pallida, and E. angustifolia, can be easily classified by the distribution and relative content of metabolites. A mitogen-induced murine skin inflammation study suggested that alkamides were the active anti-inflammatory components present in Echinacea plants. Mixed alkamides and the major component, dodeca-2E,4E,8Z,10Z(E)-tetraenoic acid isobutylamides (8/9), were then isolated from E. purpurea root extracts for further bioactivity elucidation. In macrophages, the alkamides significantly inhibited cyclooxygenase 2 (COX-2) activity and the lipopolysaccharide-induced expression of COX-2, inducible nitric oxide synthase and specific cytokines or chemokines [i.e., TNF-α, interleukin (IL)-1α, IL-6, MCP-1, MIP-1β] but elevated heme oxygenase-1 protein expression. Cichoric acid, however, exhibited little or no effect. The results of high-performance liquid chromatography/electron spray ionization/mass spectrometry metabolite profiling of alkamides and phenolic compounds in E. purpurea roots showed that specific phytocompound (i.e., alkamides, cichoric acid and rutin) contents were subject to change under certain post-harvest or abiotic treatment. This study provides new insight in using the emerging metabolomics approach coupled with bioactivity assays for medicinal/nutritional plant species classification, quality control and the identification of novel botanical agents for inflammatory disorders.</description><dc:title>Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants - Corrected Proof</dc:title><dc:creator>Chia-Chung Hou, Chun-Houh Chen, Ning-Sun Yang, Yi-Ping Chen, Chiu-Ping Lo, Sheng-Yang Wang, Yin-Jing Tien, Pi-Wen Tsai, Lie-Fen Shyur</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-11</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-11</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900165X/abstract?rss=yes"><title>Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900165X/abstract?rss=yes</link><description>Abstract: The first results of the PREDIMED (PREvencion con Dieta MEDiterranea) randomized trial, after 3-month intervention, showed that the Mediterranean Diet (MD), supplemented with either virgin olive oil (VOO) or nuts, reduced systolic blood pressure, serum cholesterol and triacylglycerol (TG) concentrations and increased high-density lipoprotein (HDL)-cholesterol when compared to a control (low-fat diet) group. Serum TG levels are an independent risk factor for coronary heart disease and are strongly determined by very low-density lipoprotein (VLDL) composition, which can be specifically modified by dietary lipid source. Within the context of the PREDIMED study, we assessed the VLDL composition in 50 participants after 3 months of intake of two MD, supplemented with VOO or nuts, compared with a low-fat diet. Total and low-density lipoprotein cholesterol concentrations were reduced in subjects on the MD+nuts, whereas HDL-cholesterol increased after consumption of the MD+VOO. Serum TG concentrations were significantly lowered in both intervention groups (either the MD+nuts or MD+VOO). However, only the MD+VOO reduced the VLDL-cholesterol and VLDL-TG content and the TG/apolipoprotein B ratio in VLDL, which was used to estimate particle size. Although VLDL-TG fatty acids were very slightly modified, VLDL-TG molecular species in VLDL after consumption of the MD+nuts were characterized by a higher presence of linoleic acid (18:2, n-6), whereas after the intake of MD+VOO, they were rich in oleic acid (18:1, n-9). Therefore, we conclude that the reduction in systemic TG concentrations observed after consumption of the MD may be explained by reduction of the lipid core of VLDL and a selective modification of the molecular species composition in the particle.</description><dc:title>Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects - Corrected Proof</dc:title><dc:creator>Javier S. Perona, María-Isabel Covas, Montserrat Fitó, Rosana Cabello-Moruno, Fernando Aros, Dolores Corella, Emilio Ros, Maria Garcia, Ramon Estruch, Miguel A. Martinez-Gonzalez, Valentina Ruiz-Gutierrez</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001727/abstract?rss=yes"><title>Effects of a grapeseed procyanidin extract (GSPE) on insulin resistance - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001727/abstract?rss=yes</link><description>Abstract: Flavonoids are beneficial compounds against risk factors for metabolic syndrome, but their effects and the mechanisms on glucose homeostasis modulation are not well defined. In the present study, we first checked the efficacy of grapeseed procyanidin extract (GSPE) for stimulating glucose uptake in insulin-resistant 3T3-L1 adipocytes. Results show that when resistance is induced with chronic insulin treatment, GSPE maintain a higher stimulating capacity than insulin. In contrast, when dexamethasone is used as the resistance-inducing agent, GSPE is less effective. Next we evaluated how effective different GSPE treatments are at improving glucose metabolism in hyperinsulinemic animals (fed a cafeteria diet). GSPE reduced plasma insulin levels. The lower dose (25 mg GSPE/kg body weight per day) administered for 30 days improved the HOmeostasis Model Assessment-insulin resistance index. This was accompanied by down-regulation of Pparg2, Glut4 and Irs1 in mesenteric white adipose tissue. Similarly, a chronic GSPE treatment of insulin-resistant 3T3-L1 adipocytes down-regulated the mRNA levels of those adipocyte markers, although cells were still able to respond to the acute stimulation of glucose uptake.In summary, 25 mg/kg body weight per day of GSPE has a positive long-term effect on glucose homeostasis, and GSPE could be targeted at adipose tissue, where it might directly stimulate glucose uptake. This work also highlights the need to carefully consider the bioactive dose, since a higher dose does not necessarily correlate to a greater positive effect.</description><dc:title>Effects of a grapeseed procyanidin extract (GSPE) on insulin resistance - Corrected Proof</dc:title><dc:creator>Gemma Montagut, Cinta Bladé, Mayte Blay, Juan Fernández-Larrea, Gerard Pujadas, M. Josepa Salvadó, Lluís Arola, Montserrat Pinent, Anna Ardévol</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001739/abstract?rss=yes"><title>Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001739/abstract?rss=yes</link><description>Abstract: The purpose of this study was to explore the bioavailability, efficacy and molecular mechanisms of green tea polyphenols (GTP) related to preventing bone loss in rats with chronic inflammation. A 2 [placebo vs. lipopolysaccharide (LPS)]×2 (no GTP vs. 0.5% GTP in drinking water) factorial design enabled the evaluation of effects of LPS administration, GTP levels, and LPS×GTP interaction. Urinary GTP components and 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels were determined by high-pressure liquid chromatography for bioavailability and molecular mechanism, respectively. Efficacy was evaluated by examining changes in femoral mineral content (BMC) and density (BMD) using dual-energy X-ray absorptiometry, and bone turnover biomarkers [osteocalcin (OC) and tartrate-resistant acid phosphatase (TRAP)] using respective ELISA kits. The mRNA expression of tumor necrosis factor-α (TNF-α) and cyclooxygenase-2 (COX-2) in spleen was determined by real-time RT-PCR. Neither LPS administration nor GTP levels affected body weight and femoral bone area throughout the study period. Only GTP supplementation resulted in increased urinary epigallocatechin and epicatechin concentrations. LPS administration led to a decrease in femur BMC and BMD, and serum OC levels, but an increase in serum TRAP, urinary 8-OHdG and spleen mRNA expression of TNF-α and COX-2 levels. GTP supplementation resulted in higher values for femur BMC, BMD and serum OC, but lower values for serum TRAP, urinary 8-OHdG and spleen mRNA expression of TNF-α and COX-2 levels. We conclude that GTP mitigates bone loss in a chronic inflammation-induced bone loss model by reducing oxidative stress-induced damage and inflammation.</description><dc:title>Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model - Corrected Proof</dc:title><dc:creator>Chwan-Li Shen, James K. Yeh, Jay J. Cao, Owatha L. Tatum, Raul Y. Dagda, Jia-Sheng Wang</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001806/abstract?rss=yes"><title>Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001806/abstract?rss=yes</link><description>Abstract: Metallothioneins (MT), the antioxidant zinc-binding proteins, seem to mediate cardioprotection. It has been postulated that zinc homeostasis and MT function may be altered, as a consequence of oxidative stress, in cardiovascular disease (CVD), with a potential implication of MT genetic polymorphisms. The present study explores the role of +647A/C and +1245A/G MT1A polymorphisms on the susceptibility to CVD, zinc status and enzyme antioxidant activity, in the Greek and Italian populations. The country selection was based on the lower zinc status and the reduced zinc dietary intake in Greece than in Italy despite the similar Mediterranean dietary pattern. A total of 464 old, healthy control subjects and 369 old CVD patients more than 70 years of age were studied. Logistic regression model indicated that +1245 MT1A G+ genotype significantly increased the risk of CVD in Greece (34.4% vs. 23.2%; odds ratio=1.88, 95% confidence interval=1.14–3.08; P=.013) but not in Italy. Haplotype analysis showed an increment of CG haplotype frequency in CVD Greek patients (17.4% vs. 10.6%, P&lt;.05). Differential country-related frequency distribution was also recorded. Applying a multivariate regression model, +647/+1245 MT1A haplotype was associated with a modulation of enzyme antioxidant activities in both countries. Decreased plasma zinc and reduced intracellular Zn release, as well as increased enzyme antioxidant activity, were more apparent in Greek healthy donors than in Italy. In conclusion, +1245 MT1A polymorphism and +647/+1245 MT1A haplotype are implicated in CVD in Greece but not in Italy, suggesting a role of gene–diet interaction in the disease predisposition.</description><dc:title>Association of MT1A haplotype with cardiovascular disease and antioxidant enzyme defense in elderly Greek population: comparison with an Italian cohort - Corrected Proof</dc:title><dc:creator>Robertina Giacconi, Stavroula Kanoni, Patrizia Mecocci, Marco Malavolta, Dimitris Richter, Sara Pierpaoli, Laura Costarelli, Catia Cipriano, Elisa Muti, Francesca Mangialasche, Francesco Piacenza, Silvia Tesei, Roberta Galeazzi, Eirini V. Theodoraki, Fabrizia Lattanzio, George Dedoussis, Eugenio Mocchegiani</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001909/abstract?rss=yes"><title>Green tea polyphenol (−)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001909/abstract?rss=yes</link><description>Abstract: Green tea polyphenol (−)-epigallocatechin gallate (EGCG) has been reported to reduce neuronal damage after cerebral ischemic insult. EGCG is known to reduce matrix metalloproteinase (MMP) activity. MMP can play an important role in the pathophysiology of neurological disorders including cerebral ischemia. The purpose of the current study was to investigate whether EGCG shows an inhibitory effect on MMP activity and neural tissue damage following transient focal cerebral ischemia. In the present study, C57BL/6 mice were subjected to 80 min of focal ischemia induced by middle cerebral artery occlusion (MCAO). Animals were killed 24 h after ischemia. EGCG (50 mg/kg) was administered intraperitoneally immediately after ischemia. Gelatin gel zymography showed an increase in the active form of MMP-9 after ischemia. EGCG reduced ischemia-induced up-regulation of the active form of MMP-9. In in situ zymography, EGCG reduced up-regulation of gelatinase activity induced by cerebral ischemia. Co-incubation with EGCG reduced gelatinase activity directly in postischemic brain section. In 2,3,5-triphenyltetrazolium chloride (TTC) assay, brain infarction was remarkable in the middle cerebral artery territory after focal cerebral ischemia. In EGCG-treated mice, infarct volume was significantly reduced compared with vehicle-treated mice. These results demonstrate that EGCG, a green tea polyphenol, may reduce up-regulation of MMP-9 activity and neuronal damage following transient focal cerebral ischemia. In addition to its antioxidant effect, MMP-9 inhibition might be a possible mechanism potentially involved in the neuroprotective effect of a green tea polyphenol, EGCG.</description><dc:title>Green tea polyphenol (−)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia - Corrected Proof</dc:title><dc:creator>Jong-Wook Park, Jung-Seok Hong, Kyoung-Suk Lee, Hahn-Young Kim, Jung-Jeung Lee, Seong-Ryong Lee</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-07</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-07</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309002083/abstract?rss=yes"><title>Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309002083/abstract?rss=yes</link><description>Abstract: We hypothesized that consumption of soy protein isolate (SPI) or the soy isoflavone genistein (GEN) would modulate mRNA expression of genes underlying lipid and thyroid hormone metabolism in livers and small intestines of young adult male Sprague–Dawley rats. Early pregnant rat dams were placed on AIN-93G diets containing casein (CAS, control protein), SPI, or CAS+GEN. Litters were weaned to the same diet as their dam. SPI-fed (but not GEN-fed) male rats of 48 days of age had significant reductions in body weight, abdominal fat pad weight and hepatic content of lipid droplets and triglycerides. Hepatic peroxisome proliferator-activated receptor α (Ppara) transcripts were elevated with SPI but not GEN diet. Hepatic pyruvate dehydrogenase kinase-4 (Pdk4) and cytochrome P450 4A10 (Cyp4a10) mRNA abundance was reduced with SPI; the SPI effect on Cyp4a10 was recapitulated by GEN diet. SPI (but not GEN) suppressed Pdk4 and 3-hydroxy-3-methylglutaryl-CoA synthase 2 (Hmgcs2) mRNA abundance in duodenum. Liver iodothyronine deiodinase types 1 and 2 (Dio1 and Dio2) mRNA levels were increased with SPI diet; the effect on Dio2, but not Dio1 mRNAs, also was observed with GEN. SPI and GEN increased hepatic types 1 and 2 iodothyronine deiodinase (D1 and D2) activities. Effects of SPI and GEN on the above gene expression may contribute to the observed reductions in body and adipose tissue weight and liver lipid content in this model. Identification of the regulation, by genistein and soy protein, of iodothyronine deiodinase synthesis has potential applications for treatment and prevention of fatty liver disease and obesity.</description><dc:title>Soy protein diet alters expression of hepatic genes regulating fatty acid and thyroid hormone metabolism in the male rat - Corrected Proof</dc:title><dc:creator>Frank A. Simmen, Charles P. Mercado, Ann Marie Zavacki, Stephen A. Huang, Amy D. Greenway, Ping Kang, Margaret T. Bowman, Ronald L. Prior</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.008</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-04</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-04</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001326/abstract?rss=yes"><title>Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001326/abstract?rss=yes</link><description>Abstract: Backgound: Animal studies suggest that reactive oxygen species (ROS) play an important role in the development of diabetic cardiomyopathy.Hypothesis: Matrix metalloproteinase-2 (MMP-2) is activated by ROS and contributes to the acute loss of myocardial contractile function by targeting and cleaving susceptible proteins including troponin I (TnI) and α-actinin.Methods: Using the streptozotocin-induced diabetic rat model, we evaluated the effect of daily in vivo administration of sodium selenate (0.3 mg/kg; DMS group), or a pure omega-3 fish oil with antioxidant vitamin E (omega-3E; 50 mg/kg; DMFA group), which has antioxidant-like effects, for 4 weeks on heart function and on several biochemical parameters related to oxidant stress and MMP-2.Results: Although both treatments prevented the diabetes-induced depression in left ventricular developed pressure (LVDP) as well as the rates of changes in developed pressure (±dP/dt) (P&lt;.001), the improvement in LVDP of the DMS group was greater compared to that of the DMFA group (P&lt;.001). Moreover, these treatments reduced the diabetes-induced increase in myocardial oxidized protein sulfhydryl and nitrite concentrations (P&lt;.001). Gelatin zymography and Western blot data indicated that the diabetes-induced changes in myocardial levels of MMP-2 and tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) and the reduction in TnI and α-actinin protein levels were improved in both the DMS and DMFA groups (P&lt;.001).Conclusions: These results suggest that diabetes-induced alterations in MMP-2 and TIMP-4 contribute to myocardial contractile dysfunction by targeting TnI and α-actinin and that sodium selenate or omega-3E could have therapeutic benefits in diabetic cardiomyopathy.</description><dc:title>Antioxidant treatment protects diabetic rats from cardiac dysfunction by preserving contractile protein targets of oxidative stress - Corrected Proof</dc:title><dc:creator>Aslihan Aydemir-Koksoy, Ayca Bilginoglu, Meltem Sariahmetoglu, Richard Schulz, Belma Turan</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001636/abstract?rss=yes"><title>Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin α′ subunit involved in Hep G2 cell cholesterol homeostasis - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001636/abstract?rss=yes</link><description>Abstract: A truncated form of α′ chain (tα′), the soybean 7S globulin subunit previously demonstrated to be active in controlling the cholesterol and triglyceride homeostasis in in vitro and in vivo models, was cloned and expressed in the yeast Pichia pastoris. The recombinant polypeptide spanned 216 amino acid residues from the N-terminal side and included the N-terminal extension region of the soybean subunit. The tα′ polypeptide was purified by conventional biochemical techniques, and its potential to modulate the activity of low-density lipoprotein (LDL) receptor was evaluated in a human hepatoma cell line (Hep G2) by monitoring the uptake and degradation of labeled LDL. The LDL uptake (+192%) and degradation (+143%) by cells tested at the highest tα′ dose (8 μM) were similar to those found in cells incubated with 1 μM simvastatin, a potent inhibitor of cholesterol biosynthesis. The cell response to tα′ was found to be dose dependent. The use of a recombinant polypeptide ruled out the involvement of any other soybean component.These findings open new prospects in the studies aimed at identifying soybean regulatory (poly)peptide(s) and the mechanism involved in this biological response, as a gateway to their utilization for the management of human health.</description><dc:title>Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin α′ subunit involved in Hep G2 cell cholesterol homeostasis - Corrected Proof</dc:title><dc:creator>Alessandro Consonni, Maria Rosa Lovati, Cristina Manzoni, Anna Pizzagalli, Paolo Morazzoni, Marcello Duranti</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.003</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001648/abstract?rss=yes"><title>A moderate threonine deficiency affects gene expression profile, paracellular permeability and glucose absorption capacity in the ileum of piglets - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001648/abstract?rss=yes</link><description>Abstract: High dietary threonine extraction by the digestive tract suggests that threonine contributes to maintain gut physiology. In the present study, we evaluated the impact of a low (6.5 g of threonine/kg diet; LT group) or a control well-balanced threonine diet (9.3 g of threonine/kg diet; C group) given to piglets for 2 weeks on ileal permeability and Na+-dependant glucose absorption capacity in Ussing chambers. The paracellular permeability was significantly increased in the ileum of LT compared to C piglets (P=.017). The Na+-dependent glucose absorption capacity showed a nonsignificant increase in the LT piglets. In addition, we analysed ileal gene expression profiles in the LT and C groups using porcine multitissue cDNA microarrays. Compared to the C piglets, the expression of 324 genes was significantly modified in the ileum of the LT piglets: 214 genes were overexpressed (145 annotated) and 110 were down-expressed (79 annotated). Among them, some are involved in immune and defense responses, energy metabolism and protein synthesis. Furthermore, microarray analysis highlights changes in the expression of the gene encoding for the sodium/glucose cotransporter (SGLT1) and of genes involved in the regulation of paracellular permeability (ZO-1, cingulin and myosin light chain kinase). In conclusion, our results indicate that a moderate threonine deficiency affects intestinal functionality.</description><dc:title>A moderate threonine deficiency affects gene expression profile, paracellular permeability and glucose absorption capacity in the ileum of piglets - Corrected Proof</dc:title><dc:creator>Alice Hamard, David Mazurais, Gaëlle Boudry, Isabelle Le Huërou-Luron, Bernard Sève, Nathalie Le Floc'h</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001661/abstract?rss=yes"><title>Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001661/abstract?rss=yes</link><description>Abstract: Oleoylethanolamide (OEA) has been previously reported to regulate food intake and body weight gain when administered intraperitoneally. Nevertheless, little information is available with regard to oral administration. To assess whether oral OEA can also exert a similar effect on body fat, we fed C3H mice a high-fat diet supplemented with either 10 or 100 mg/kg body weight OEA for 4 weeks. OEA supplementation significantly lowered food intake over the 4 weeks and decreased adipose tissue mass. Plasma triglyceride levels were also significantly decreased by OEA treatment. In order to identify the potential molecular targets of OEA action, we screened the expression levels of 44 genes related to body fat mass and food intake in peripheral tissues. Adipose tissue fatty acid amide hydrolase (FAAH), intestinal fatty acid transporter/cluster of differentiation 36 and the OEA receptor G-protein-coupled receptor 119 (GPR119) were among the most OEA-responsive genes. They were also associated with reduced body fat pads regardless of the dose. Adipose FAAH was found to be primarily associated with a decrease in food intake. Our data suggest that the anti-obesity activity of OEA partially relies on modulation of the FAAH pathway in adipose tissue. Another mechanism might involve modulation of the newly discovered GPR119 OEA signaling pathway in the proximal intestine. In conclusion, our study indicates that oral administration of OEA can effectively decrease obesity in the mouse model and that modulation of the endocannabinoid fatty acid ethanolamide pathway seems to play an important role both in adipose tissue and in small intestine.</description><dc:title>Analysis of gene expression pattern reveals potential targets of dietary oleoylethanolamide in reducing body fat gain in C3H mice - Corrected Proof</dc:title><dc:creator>Clémentine Thabuis, Frédéric Destaillats, Jean-François Landrier, Delphine Tissot-Favre, Jean-Charles Martin</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001673/abstract?rss=yes"><title>Dietary fish oil inhibits the early stage of recovery of atrophied soleus muscle in rats via Akt–p70s6k signaling and PGF2α - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001673/abstract?rss=yes</link><description>Abstract: Skeletal muscle recovery from disuse atrophy requires the recruitment of insulin signaling for muscle growth, which is driven by protein synthesis. Dietary fish oil, which is rich in long-chain n−3 polyunsaturated fatty acids, is known to enhance insulin signaling and protein metabolism. Therefore, this study was performed to evaluate whether dietary fish oil facilitates muscle recovery during remobilization after disuse atrophy. Ten days of immobilization, followed by 3 or 13 days of remobilization, were applied to the hindlimbs of rats fed corn oil [corn oil diet group as control (CO)] or fish oil [fish oil diet group (FO)] as source of dietary fat. The immobilization-induced reductions in soleus muscle weight and myosin heavy-chain content were significantly restored by 3 days of remobilization in CO. However, in FO, these muscle recovery measurements did not significantly change until 13 days of remobilization. At 3 days of remobilization, both groups had significant elevations in p70 ribosomal S6 kinase (p70s6k) activation and at a greater extent in CO than in FO. The activation of Akt was also increased on Day 3, but it was not significant in FO. Throughout the remobilization period, levels of prostaglandin F2α (PGF2α) and cyclooxygenase-2 mRNA were significantly augmented. However, FO had a lesser increase in PGF2α than CO until Day 13. These findings indicate that dietary fish oil inhibits the early stage of soleus muscle recovery after disuse atrophy by suppressing the activation of Akt–p70s6k signaling and PGF2α synthesis.</description><dc:title>Dietary fish oil inhibits the early stage of recovery of atrophied soleus muscle in rats via Akt–p70s6k signaling and PGF2α - Corrected Proof</dc:title><dc:creator>Jae-Sung You, Mi-Na Park, Yeon-Sook Lee</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001697/abstract?rss=yes"><title>Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001697/abstract?rss=yes</link><description>Abstract: Obesity and insulin resistance have been linked to a low-grade chronic inflammatory response characterized by increased macrophage infiltration, altered cytokine production and activation of inflammatory signaling pathway in adipose tissue. Pharmacological agents and natural products that are capable of reducing inflammatory activity possess anti-diabetic properties. Luteolin, a naturally occurring flavonoid, has been demonstrated to inhibit lipopolysaccharide-induced tumor necrosis factor-α (TNFα) release and activation of NF-κB pathway in macrophages. However, little is known about the mechanism and effect of luteolin on inflammation-related insulin resistance in adipocytes. In this study, we investigated the effect of luteolin on insulin action in 3T3-L1 adipocytes and primary adipose cells. Here we showed that luteolin treatment for 24 h increased the response of glucose uptake to insulin stimulation in 3T3-L1 adipocytes. Our results also demonstrated that luteolin enhanced Akt2 phosphorylation in an insulin-stimulated state. Furthermore, luteolin treatment decreased mRNA levels of TNFα, interleukin-6 and MCP-1, while it increased the gene expression of adiponectin and leptin in 3T3-L1 adipocytes and primary mouse adipose cells. Most interestingly, we found that treatment of luteolin markedly enhanced peroxisome proliferator-activated receptor γ (PPARγ) transcriptional activity in 3T3-L1 adipocytes, and luteolin-increased expression of adiponectin and leptin was blocked by GW9662, a PPARγ antagonist. Thus, our data suggest that luteolin influences insulin action and production of adipokines/cytokines in adipocytes by activating the PPARγ pathway.</description><dc:title>Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes - Corrected Proof</dc:title><dc:creator>Li Ding, Daozhong Jin, Xiaoli Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.009</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001703/abstract?rss=yes"><title>Reduction in cardiovascular risk by sodium-bicarbonated mineral water in moderately hypercholesterolemic young adults - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001703/abstract?rss=yes</link><description>Abstract: The effects of drinking sodium-bicarbonated mineral water on cardiovascular risk in young men and women with moderate cardiovascular risk were studied. Eighteen young volunteers (total cholesterol levels &gt;5.2 mmol/L) without any disease participated. The study consisted of two 8-week intervention periods. Subjects consumed, as supplement to their usual diet, 1 L/day control low mineral water, followed by 1 L/day bicarbonated mineral water (48 mmol/L sodium, 35 mmol/L bicarbonate and 17 mmol/L chloride). Determinations were performed at the end of the control water period and on Weeks 4 and 8 of the bicarbonated water period. Body weight, body mass index (BMI), blood pressure, dietary intake, total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, apolipoprotein (Apo) A-I, Apo B, triacylgycerols, glucose, insulin, adiponectin, high-sensitivity C-reactive protein (hs-CRP), soluble adhesion molecules [soluble intercellular adhesion molecule (sICAM) and soluble vascular adhesion molecule (sVCAM)], sodium and chloride urinary excretion, and urine pH were measured. Dietary intake, body weight and BMI showed no significant variations. Systolic blood pressure decreased significantly after 4 weeks of bicarbonated water consumption, without significant differences between Weeks 4 and 8. After bicarbonated water consumption, significant reductions in total cholesterol (by 6.3%; P=.012), LDL cholesterol (by 10%; P=.001), total/HDL cholesterol (P=.004), LDL/HDL cholesterol (P=.001) and Apo B (P=.017) were observed. Serum triacylglycerol, Apo A-I, sICAM-1, sVCAM-1 and hs-CRP levels did not change. Serum glucose values tended to decrease during the bicarbonated water intervention (P=.056), but insulin levels did not vary. This sodium-bicarbonated mineral water improves lipid profile in moderately hypercholesterolemic young men and women and could therefore be applied in dietary interventions to reduce cardiovascular risk.</description><dc:title>Reduction in cardiovascular risk by sodium-bicarbonated mineral water in moderately hypercholesterolemic young adults - Corrected Proof</dc:title><dc:creator>Ana M. Pérez-Granados, Santiago Navas-Carretero, Stefanie Schoppen, M. Pilar Vaquero</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.010</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001715/abstract?rss=yes"><title>Dietary fish oil n-3 polyunsaturated fatty acids and alpha-linolenic acid differently affect brain accretion of docosahexaenoic acid and expression of desaturases and sterol regulatory element-binding protein 1 in mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001715/abstract?rss=yes</link><description>Abstract: Whether preformed dietary docosahexaenoic acid (DHA) is required for brain accretion has not been clearly determined. In this study, we investigated in mice the different effects of dietary longer-chain n-3 polyunsaturated fatty acids (PUFAs) and α-linolenic acid (LNA) on brain accretion of DHA and the expression of associated desaturases and transcription factors. C57 BL/6J mice were fed for 3 months with four fish oil n-3 PUFA diets — lower, low, high and higher (0.46%, 0.91%, 1.73% and 4.29% total energy, respectively); a flaxseed oil n-3 PUFA (5.01% total energy) diet; and an n-3 PUFA-deficient diet, respectively. Either fish oil or flaxseed oil n-3 PUFA diets increased DHA concentrations in the brain. However, the flaxseed oil n-3 PUFA diet was less effective than the fish oil diet with higher amount of n-3 PUFA in increasing brain DHA content. Furthermore, the expressions of delta-6 desaturase (D6D) and sterol regulatory element binding protein 1 (SREBP-1) in the liver were down-regulated by all fish oil diets with different amounts of n-3 PUFAs, as well as by the flaxseed oil n-3 PUFA diet, whereas in the brain, D6D, delta-5 desaturase (D5D) and SREBP-1 expressions were down-regulated by the higher fish oil n-3 PUFA diet rather than by other fish oil n-3 PUFA and the flaxseed oil n-3 PUFA diets. These results suggest that preformed dietary DHA, different from those converted by LNA inside the body, is better for brain accretion. Dietary longer-chain n-3 PUFAs affect expressions of D6D, D5D and SREBP-1 in the brain differently from their precursor LNA.</description><dc:title>Dietary fish oil n-3 polyunsaturated fatty acids and alpha-linolenic acid differently affect brain accretion of docosahexaenoic acid and expression of desaturases and sterol regulatory element-binding protein 1 in mice - Corrected Proof</dc:title><dc:creator>Haiyan Zhu, Chaonan Fan, Feng Xu, Chunyu Tian, Feng Zhang, Kemin Qi</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001740/abstract?rss=yes"><title>Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001740/abstract?rss=yes</link><description>Abstract: Lecithin:retinol acyltransferase (LRAT) regulates retinol (vitamin A) metabolism by esterifying retinol. LRAT expression is decreased in cultured human squamous cell carcinoma cells of the head and neck relative to normal epithelial cells. We investigated whether the carcinogen 4-nitroquinoline 1-oxide (4-NQO) induced a higher incidence of oral cancer in LRAT knockout (LRAT−/−) than in wild-type (Wt) mice. We also investigated retinol deprivation during 4-NQO treatment in LRAT−/− mice as a model for rapid retinol deficiency. We observed higher levels of secreted frizzled-related protein (Sfrp) 2, an inhibitor of WNT signaling, in tongue tumors in LRAT−/− versus Wt. LRAT−/− embryonic stem cells also expressed higher Sfrp2 transcripts, indicating an interaction between retinol and WNT signaling. Cox-2, Cyclin D1, p21, Trop2 and RARβ2 were not differentially expressed in Wt versus LRAT−/− tongue tumors. Wt and LRAT−/− mice fed a retinol-sufficient diet showed the same oral tumor incidence after 4-NQO treatment. In contrast, tongue tumors developed in 60% of Wt mice and in 100% of LRAT−/− mice fed a retinol-deficient diet during 4-NQO treatment (P=.22); moreover, the bromodeoxyuridine labeling index was 21.0±2.4% in LRAT−/− normal tongue epithelium as compared to 9.9±0.8% in Wt normal tongue epithelium (P&lt;.001). Thus, partial retinol deficiency during carcinogen treatment (achieved in LRAT−/−) resulted in more proliferating cells in tongue epithelia from LRAT−/− mice and, ultimately, a greater probability of carcinogenesis.</description><dc:title>Oral carcinogenesis induced by 4-nitroquinoline 1-oxide in lecithin:retinol acyltransferase gene knockout mice - Corrected Proof</dc:title><dc:creator>Limin Liu, Xiao-Han Tang, Theresa Scognamiglio, Lorraine J. Gudas</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.012</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001764/abstract?rss=yes"><title>Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001764/abstract?rss=yes</link><description>Abstract: Fasting and postprandial triacylglycerol (TAG) concentrations are risk factors for cardiovascular disease. This study evaluated whether interleukin-6 (IL-6) and incretin hormones [gastric inhibitory peptide (GIP) and glucagon-like peptide-1 (GLP-1) (active)] were associated with fasting and postprandial TAG in response to an oral lipid load, including very-low-density lipoprotein (VLDL) and chylomicron (CM) TAG, following one bout of exercise in nine men (age, 59±2 years; body mass index, 34±2 kg/m2; waist circumference, 113±3 cm) with high fasting TAG (2.9±0.2 mmol/L). Subjects completed two oral fat tolerance tests (OFTTs), randomized 1 week apart, that consisted of 1g fat/kg body weight emulsified lipids in the absence of carbohydrate and protein. Approximately 16 h prior to one OFTT, subjects completed 60 min of treadmill walking (estimated 55% VO2 peak; heart rate, 122±4 beats/min). No exercise was performed on the day before the other OFTT. Fasted (0 h) and postprandial (1, 2, 3, 4, 5 and 6 h) blood samples were taken for analysis of TAG, IL-6 and incretins. Subcutaneous adipose tissue biopsies were taken at 0 and 6 h after OFTT ingestion for IL-6 and GIP receptor (GIPr) mRNA quantification. Exercise lowered fasting and postprandial TAG (P .05). Fasting and postprandial plasma IL-6, GIP and GLP-1 did not differ between rest and exercise OFTT trials (P&gt;.05). Exercise reduced IL-6 and GIPr mRNA (P&lt;.05) in adipose tissue. Our results suggest that the reduction in VLDL TAG following an acute bout of exercise is not associated with circulating IL-6 or incretin concentrations, despite reductions in the adipose tissue expression of IL-6 and GIPr.</description><dc:title>Exercise prior to fat ingestion lowers fasting and postprandial VLDL and decreases adipose tissue IL-6 and GIP receptor mRNA in hypertriacylglycerolemic men - Corrected Proof</dc:title><dc:creator>Mark J. Dekker, Terry E. Graham, T.C. Ooi, Lindsay E. Robinson</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.004</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001776/abstract?rss=yes"><title>Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001776/abstract?rss=yes</link><description>Abstract: Further clarification is needed to address the paradox that memory formation, aging and neurodegeneration all involve calcium influx, oxyradical production (ROS) and activation of certain signaling pathways. In aged rats and in APP/PS-1 mice, cognitive and hippocampal Ca2+ dysregulation was reversed by food supplementation with a high antioxidant blueberry extract. Here, we studied whether neurons were an important target of blueberry extract and whether the mechanism involved altered ROS signaling through MAP kinase and cyclic-AMP response element binding protein (CREB), pathways known to be activated in response to amyloid-beta (Aβ). Primary hippocampal neurons were isolated and cultured from embryonic, middle-age or old-age (24 months) rats. Blueberry extract was found to be equally neuroprotective against Aβ neurotoxicity at all ages. Increases in Aβ toxicity with age were associated with age-related increases in immunoreactivity of neurons to pERK and an age-independent increase in pCREB. Treatment with blueberry extract strongly inhibited these increases in parallel with neuroprotection. Simultaneous labeling for ROS and for glutathione with dichlorofluorescein and monochlorobimane showed a mechanism of action of blueberry extract to involve transient ROS generation with an increase in the redox buffer glutathione. We conclude that the increased age-related susceptibility of old-age neurons to Aβ toxicity may be due to higher levels of activation of pERK and pCREB pathways that can be protected by blueberry extract through inhibition of both these pathways through an ROS stress response. These results suggest that the beneficial effects of blueberry extract may involve transient stress signaling and ROS protection that may translate into improved cognition in aging rats and APP/PS1 mice given blueberry extract.</description><dc:title>Age-related toxicity of amyloid-beta associated with increased pERK and pCREB in primary hippocampal neurons: reversal by blueberry extract - Corrected Proof</dc:title><dc:creator>Gregory J. Brewer, John R. Torricelli, Amanda L. Lindsey, Elizabeth Z. Kunz, A. Neuman, Derek R. Fisher, James A. Joseph</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.005</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001788/abstract?rss=yes"><title>High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001788/abstract?rss=yes</link><description>Abstract: Chronic renal failure (CRF) is associated with malnutrition and renal tissue accumulation of lipids, which can contribute to progression of renal disease. This study was designed to explore the effect of a high-calorie diet on pathways involved in lipid metabolism in the remnant kidney of rats with CRF. 5/6 nephrectomized rats were randomized to receive a regular diet (3.0 kcal/g) or a high-calorie diet (4.5 kcal/g) for 12 weeks. Renal lipid contents and abundance of molecules involved in cholesterol and fatty acid metabolism were studied. The CRF group consuming a regular diet exhibited growth retardation; azotemia; proteinuria; glomerulosclerosis; tubulointerstitial injury; heavy lipid accumulation in the remnant kidney; up-regulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), ATP-binding cassette transporter-1 (ABCA1), liver X receptor (LXR) α/β, carbohydrate-responsive element binding protein (ChREBP) and acyl-CoA carboxylase (ACC); and down-regulation of peroxisome proliferator-activated receptor-α (PPAR-α), carnitine palmitoyltransferase-1 (CPT1) and liver-type fatty acid binding protein (L-FABP). The high-calorie diet restored growth; reduced the severity of tubulointerstitial injury, proteinuria and azotemia; partially lowered renal tissue lipid contents; attenuated the up-regulation of mediators of lipid influx (LOX-1), lipid efflux (LXR-α/β and ABCA1) and fatty acid biosynthesis (ChREBP and ACC); and reversed the down-regulation of factors involved in fatty acid oxidation (PPAR-α, CPT1 and L-FABP). In conclusion, a high-calorie diet restores growth, improves renal function and structure, and lowers lipid burden in the remnant kidney. The latter is associated with and most likely due to reduction in lipid influx and enhancement of fatty acid oxidation.</description><dc:title>High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney - Corrected Proof</dc:title><dc:creator>Hyun Ju Kim, Jun Yuan, Keith Norris, Nosratola D. Vaziri</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.006</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900179X/abstract?rss=yes"><title>A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900179X/abstract?rss=yes</link><description>Abstract: The timing of dietary fat intake may modify breast cancer risk. In addition, n-3 fatty acids reduce, and n-6 fatty acids increase, the risk of breast cancer and a maternal high n-6 fat diet results in a greater risk of breast cancer in the female offspring. We hypothesized that the timing of n-3 fatty acid-enriched fish oil supplementation would be important for reducing the risk of breast cancer. Female rats were fed to a high n-6 fat diet containing 20% of the sunflower oil by weight during pregnancy and lactation, and the female offspring were exposed to fish oil by oral gavage either during the perinatal period via maternal intake or during puberty or adulthood. Exposure during the perinatal period to a maternal high n-6 fat diet with fish oil supplementation significantly reduced the incidence of carcinogen-induced mammary tumors in the female offspring compared to a maternal high n-6 fat diet with no fish oil supplementation or fish oil supplementation later in life (P=.0228 by Cox proportional hazards model). We found that a maternal high n-6 fat diet during pregnancy is more important in increasing the risk of mammary tumors in the female offspring than a maternal high n-6 fat diet during lactation. This study suggests that fish oil supplementation during the perinatal period decreases the effect of a maternal high n-6 fat diet on subsequent carcinogen-induced mammary tumor risk, whereas fish oil supplementation during puberty or adulthood does not.</description><dc:title>A maternal high n-6 fat diet with fish oil supplementation during pregnancy and lactation in rats decreases breast cancer risk in the female offspring - Corrected Proof</dc:title><dc:creator>Hui-Min Su, Pei-Hsuan Hsieh, Hui-Feng Chen</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.08.007</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001922/abstract?rss=yes"><title>In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001922/abstract?rss=yes</link><description>Abstract: Hydroxycinnamic acids are a class of phenolic antioxidants found widely in dietary plants. Their biotransformation in the human organism primarily involves Phase II conjugation reactions. In this study, activities of UDP-glucuronosyltransferases (UGTs) and sulfotransferases (SULTs) towards major dietary hydroxycinnamic acids (caffeic, dihydrocaffeic, dihydroferulic, ferulic and isoferulic acids) were investigated. Conjugate formation was evaluated using human liver and intestinal S9 homogenates, and in vitro characterization was carried out using recombinant human UGTs and SULTs. Analysis of the kinetics of hydroxycinnamic acid conjugation in human S9 homogenates revealed that intrinsic clearance (Vmax/Km) is much greater for sulfation than for glucuronidation. Assessment of activity using a panel of recombinant human SULTs showed that SULT1A1 is most active in the sulfation of caffeic, dihydrocaffeic and isoferulic acids, while SULT1E1 is most active in the sulfation of ferulic and dihydroferulic acids. Only isoferulic acid was significantly glucuronidated by human liver S9 homogenates, explained by the high activity of liver-specific UGT1A9. Studies on the kinetics of active SULTs and UGTs demonstrated a markedly lower Km for SULTs. To further corroborate our findings, we carried out an intervention study in healthy humans to determine the hydroxycinnamic acid conjugates in urine after consumption of hydroxycinnamate-rich coffee (200 ml). Analysis showed that sulfates are the main conjugates in urine, with the exception of isoferulic acid, which is mainly glucuronidated. These data suggest that sulfates are the predominant hydroxycinnamic acid conjugates in humans, and that SULT mediated sulfation is a major factor determining the bioavailability of hydroxycinnamic acids in vivo.</description><dc:title>In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans - Corrected Proof</dc:title><dc:creator>Chi Chun Wong, Walter Meinl, Hans-Rudolf Glatt, Denis Barron, Angélique Stalmach, Heike Steiling, Alan Crozier, Gary Williamson</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001934/abstract?rss=yes"><title>Mechanisms of anti-atherosclerotic functions of soy-based diets - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001934/abstract?rss=yes</link><description>Abstract: Soy-based diets have been reported to protect against the development of atherosclerosis. However, the underlying mechanism(s) for this protection remains unknown. Although atherosclerosis was traditionally considered a disease associated with impaired lipid metabolism, in recent years the inflammatory components of atherosclerosis have been explored. Recent studies have convincingly delineated that uncontrolled chronic inflammation is the principal contributing factor for the initiation and progression of atherosclerosis. Interaction between activated monocytes and vascular endothelial cells is an early event in atherogenesis. The adhesion of leukocytes, including monocytes, to the inflamed-vascular endothelium and their transmigration into intima initiate the inflammatory processes. Following transmigration, monocytes in the intima are transformed to macrophages, which take up oxidized-LDL (oxLDL) to generate lipid-laden macrophages, also known as foam cells. Hence, in this review article the inflammatory processes associated with atherosclerosis and possible anti-inflammatory functions of soy-based diets contributing to the prevention of atherosclerosis are presented.</description><dc:title>Mechanisms of anti-atherosclerotic functions of soy-based diets - Corrected Proof</dc:title><dc:creator>Shanmugam Nagarajan</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.09.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-12-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-12-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS095528630900151X/abstract?rss=yes"><title>Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS095528630900151X/abstract?rss=yes</link><description>Abstract: A healthy diet and plant sterols (PS) are recommended for reducing low-density lipoprotein (LDL) cholesterol and, subsequently, the risk of premature cardiovascular disease. PS mediate a decrease in fat-soluble vitamin concentration, which can lead to a general impairment of antioxidative defenses and an increase in oxidative stress. Thus, we evaluated the effects of a healthy diet, including PS-enriched low-fat milk, on cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects.This was a randomized parallel trial employing 40 subjects and consisting of two 3-month intervention phases. After 3 months on a standard healthy diet, subjects were divided into two intervention groups: a diet group and a diet+PS group (2 g/day). Lipid profile, apolipoproteins, high-sensitivity C-reactive protein and oxidative stress parameters were analyzed. Diet significantly reduced total and LDL cholesterol (4.0% and 4.7%, respectively), produced an increase in the level of β-carotene (23%) and improved the antioxidant capacity of LDL cholesterol particles (4.6%). PS induced a significant decrease in total cholesterol (6.4%), LDL (9.9%) and the apolipoprotein B100/apolipoprotein A1 ratio (4.9%), but led to a decrease in cryptoxanthin level (29%) without any change being observed in the antioxidant capacity of LDL cholesterol particles, total antioxidant status or lipid peroxidation. After 3 months, we observed the positive effect of including a PS supplement in dietary measures, as the lipoprotein-mediated risk of cardiovascular disease was reduced. Despite a decrease in the concentration of cryptoxanthin, no evidence of a global impairment of antioxidative defenses or an enhancement of oxidative stress parameters was found.</description><dc:title>Evaluation of cardiovascular risk and oxidative stress parameters in hypercholesterolemic subjects on a standard healthy diet including low-fat milk enriched with plant sterols - Corrected Proof</dc:title><dc:creator>Celia Bañuls, María L. Martínez-Triguero, Antonio López-Ruiz, Carlos Morillas, Ramon Lacomba, Víctor M. Víctor, Milagros Rocha, Antonio Hernández-Mijares</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.001</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-11-04</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-11-04</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001405/abstract?rss=yes"><title>Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001405/abstract?rss=yes</link><description>Abstract: Human milk contains biological factors that are involved in a newborn's growth and immune system regulation. By integrating standard biochemical experimental protocols with computational methods, the present study investigates the presence of heme oxygenase-1 (HO-1), a cytoprotective enzyme, in human milk at different levels of maturation and in milk formulae. Furthermore, we evaluated cytokine and glutathione S-transferase (GSH) levels. Samples were collected from colostrum (on Day 1 after birth), from transition milk (on Postdelivery Days 7 and 14) and from mature milk (on Day 30 after delivery) in 14 healthy women. HO-1 protein, GSH and cytokines levels were measured using enzyme-linked immunosorbent assay and flow cytometry. HO-1 protein levels were significantly higher in colostrum (1.33 ng/ml; 5th centile 0.92; 95th centile 2.38) and in transition milk at 14 days (0.97 ng/ml; 5th centile 0.87; 95th centile 1.45) than in mature milk (0.9 ng/ml; 5th centile 0.8; 95th centile 1.38). Levels of HO-1 in milk formulae were similar to those in colostrum. No significant differences in GSH content were observed in mature milk, transition milk and colostrum, whereas significantly higher GSH levels were observed in milk formulae. No significant levels of cytokines, with the exception of interleukin-8, were found. Computational studies on the possible interactions between HO-1 and CD91 were carried out by a battery of softwares, namely, GRAMM (version 1.03), DALI, CLUSTALW (version 2.0), PatchDock and FireDock, mutually counterchecking and validating each other. The computational results, the strong convergence (to the same “solution”) of which finally leads to an “experimental-like” character, showed that HO-1 may bind to CD91, thus suggesting its major role as a new chaperokine in immune response regulation. These findings, which connect and integrate biochemical data and computational data interpretation, represent a synergistic and powerful means of conducting biological research.</description><dc:title>Potential immunoregulatory role of heme oxygenase-1 in human milk: a combined biochemical and molecular modeling approach - Corrected Proof</dc:title><dc:creator>Giovanni Li Volti, Fabio Galvano, Alessandro Frigiola, Salvatore Guccione, Claudia Di Giacomo, Stefano Forte, Giovanni Tringali, Massimo Caruso, Olayiwola Adedotun Adekoya, Diego Gazzolo</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.011</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-11-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-11-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001508/abstract?rss=yes"><title>Folic acid consumption reduces resistin level and restores blunted acetylcholine-induced aortic relaxation in obese/diabetic mice - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001508/abstract?rss=yes</link><description>Abstract: Folic acid supplementation provides beneficial effects on endothelial functions in patients with hyperhomocysteinemia. However, its effects on vascular functions under diabetic conditions are largely unknown. Therefore, the effect(s) of folic acid (5.7 and 71 μg/kg/day for 4 weeks) on aortic relaxation was investigated using obese/diabetic (+db/+db) mice and lean littermate (+db/+m) mice. Acetylcholine-induced relaxation in +db/+db mice was less than that observed in +db/+m mice. The reduced relaxation in +db/+db mice was restored by consumption of 71 μg/kg folic acid. Acetylcholine-induced relaxation (with and without folic acid treatment) was sensitive to NG-nitro-l-arginine methyl ester, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one, geldanamycin and triciribine. In addition, acetylcholine-induced relaxation was attenuated by resistin. The plasma level of resistin in +db/+db mice was sevenfold higher than that measured in +db/+m mice, and the elevated plasma level of resistin in +db/+db mice was reduced by 25% after treatment with 71 μg/kg folic acid. Folic acid slightly increased the ratio of reduced glutathione to oxidized glutathione in +db/+db mice. Moreover, folic acid caused a reduction in PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression, an increase in the phosphorylation of endothelial nitric oxide synthase (eNOSSer1177) and AktSer473, and an enhanced interaction of heat shock protein 90 (HSP90) with eNOS in both strains, with greater magnitude observed in +db/+db mice. In conclusion, folic acid consumption improved blunted acetylcholine-induced relaxation in +db/+db mice. The mechanism may be, at least partly, attributed to enhancement of PI3K/HSP90/eNOS/Akt cascade, reduction in plasma resistin level, down-regulation of PTEN and slight modification of oxidative state.</description><dc:title>Folic acid consumption reduces resistin level and restores blunted acetylcholine-induced aortic relaxation in obese/diabetic mice - Corrected Proof</dc:title><dc:creator>Sai Wang Seto, Tsz Yan Lam, Penelope Mei Yu Or, Wayne Yuk Wai Lee, Alice Lai Shan Au, Christina Chui Wa Poon, Rachel Wai Sum Li, Shun Wan Chan, John Hok Keung Yeung, George Pak Heng Leung, Simon Ming Yuen Lee, Sai Ming Ngai, Yiu Wa Kwan</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.06.015</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-11-02</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-11-02</prism:publicationDate></item><item rdf:about="http://www.jnutbio.com/article/PIIS0955286309001521/abstract?rss=yes"><title>Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds - Corrected Proof</title><link>http://www.jnutbio.com/article/PIIS0955286309001521/abstract?rss=yes</link><description>Abstract: The common food additive carrageenan (CGN) predictably induces intestinal inflammation in animal models. Mechanisms of CGN-induced nuclear factor κB and interleukin-8 (IL-8) stimulation include an immune-mediated pathway involving toll-like receptor 4 (TLR4) and B-cell lymphoma/leukemia 10 (BCL10) and a reactive oxygen species (ROS)-mediated pathway. To determine how the structure of CGN contributes to its initiation of inflammation through these two distinct mechanisms, we treated CGNs with galactosidases and carrageenases (CGNases) and determined the impact on IL-8 secretion and BCL10 production. Hydrolysis of CGN by the enzyme α-1→(3,6)-galactosidase significantly reduced increases in IL-8 and BCL10, but other galactosidases tested, including α-1→6-galactosidase, β-1→4-galactosidase and β-1→3,6-galactosidase, had no effect. In contrast, specific κ-CGNases or ι-CGNases, which hydrolyze β-1,4-galactosidic bonds, produced increases in IL-8 and BCL10 attributable to increased exposure of the immunogenic α-1→3-galactosidic epitope of CGN to TLR4. These results were consistent with induction of innate immune response by an interaction of TLR4 with the unusual α-d-Gal-(1→3)-d-Gal epitope present in CGN. Activation of the ROS-mediated pathway was unaffected by treatment of κ-CGN with either κ-CGNase (3 mg/L), α-1→(3,6)-galactosidase (20 mU/ml) or these enzymes in combination, indicating that changes in IL-8 production were attributable to the effects of induction of inflammation on the TLR4–BCL10-mediated innate immune pathway. These findings provide new information about the specificity of carbohydrate–protein interaction between CGN and TLR4 and may help to devise treatments that modify the immune reactivity induced by carbohydrate antigens.</description><dc:title>Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds - Corrected Proof</dc:title><dc:creator>Sumit Bhattacharyya, Haiying Liu, Zhenqing Zhang, Murielle Jam, Pradeep K. Dudeja, Gurvan Michel, Robert J. Linhardt, Joanne K. Tobacman</dc:creator><dc:identifier>10.1016/j.jnutbio.2009.07.002</dc:identifier><dc:source>The Journal of Nutritional Biochemistry (2009)</dc:source><dc:date>2009-10-30</dc:date><prism:publicationName>The Journal of Nutritional Biochemistry</prism:publicationName><prism:publicationDate>2009-10-30</prism:publicationDate></item></rdf:RDF>